SLAMSEQ
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

SLAMSEQ Trademark

Serial Number: 79235946 • Registration: 5658617

SLAMSEQ is a trademark filed by IMBA - Institut für Molekulare Biotechnologie GmbH on February 28, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

IMBA - Institut für Molekulare Biotechnologie GmbH

Dr. Bohr Gasse 3
Wien A-1030 , AT

Entity Type: 16

Trademark Details

Filing Date

February 28, 2018

Registration Date

January 22, 2019

Published for Opposition

November 6, 2018

Goods & Services

[ Pharmaceutical products, namely, nucleic acid molecules for use in identification of genotypes, for the preparation of biopolymer profiles, for the detection of diseases, for the detection of the progression of diseases as well as for the detection of reactions to medicines; diagnostic reagents for medical purposes in the diagnosis of inflammations, infections, diseases of the central nervous system, cardiovascular, neurologic, endocrine, autoimmune and genetic diseases and of cancer, consisting of reagents, processing chemicals and nucleic acid molecules; medical diagnostic test kits for the detection of pathogens in the environment; clinical and diagnostic reagents and preparations for medical and veterinary purposes; medical diagnostic test kits for identification, quantification and analysis of DNA or RNA; reagents and enzymes for use with effecting DNA- or RNA-analysis for medical purposes ]

Scientific and technological services, namely, scientific research, development, diagnosis and analysis in the field of diagnostic chemicals and reagents, sorting of nucleotides, separation processes and cleaning processes, chemical screening analysis and effecting of diagnostic, forensic and genetic-medical tests for thirds; scientific research and development for thirds in the fields of diagnostic chemical agents and reagents for use as diagnostic, therapeutic preparations, as well as chemical screenings and diagnosis for thirds; scientific research and development of pharmaceutical preparations for sanitary use; design of new products regarding pharmaceutical products; quality tests and quality control of scientific analyses relating to nucleic acids; scientific analyses relating to nucleic acids, in particular for detection purposes

Chemical and biochemical preparations for industrial and scientific purposes; chemical preparations for biotechnical purposes (industrial); chemical preparations for use in the development of biotechnological products for industrial and scientific purposes; chemical reagents and preparations for scientific purposes; chemical substances for analysis in laboratories and for use in kits; diagnostic reagents for in-vitro use in clinical chemistry; diagnostic preparations, except for medical or veterinary purposes; enzymes, in particular for use in kits and for use in effecting DNA-analysis or RNA-analysis and for enzyme preparations; all aforementioned goods for industrial and scientific purposes; reagents for scientific purposes

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 21, 2026 INPR
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
May 21, 2025 NA15
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 21, 2025 NA71
REGISTERED - SEC. 15 ACKNOWLEDGED
May 21, 2025 15AK
REGISTERED - PARTIAL SEC 71 ACCEPTED
May 21, 2025 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 19, 2025 APRE
TEAS SECTION 15 RECEIVED
Feb 11, 2025 E15R
TEAS SECTION 71 RECEIVED
Jan 22, 2025 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 22, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Nov 4, 2023 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 26, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 1, 2019 FINV
GENERIC MADRID TRANSACTION SENT TO IB
May 8, 2019 XXSS
GENERIC MADRID TRANSACTION CREATED
May 8, 2019 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 22, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 22, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 6, 2018 NPUB
PUBLISHED FOR OPPOSITION
Nov 6, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Nov 2, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 17, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 17, 2018 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 17, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 27, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2018 CRFA
ASSIGNED TO LIE
Sep 11, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 27, 2018 TROA
REFUSAL PROCESSED BY IB
Aug 4, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 18, 2018 RFCS
REFUSAL PROCESSED BY MPU
Jul 18, 2018 RFRR
APPLICATION FILING RECEIPT MAILED
Jul 11, 2018 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 8, 2018 RFCR
NON-FINAL ACTION WRITTEN
Jul 7, 2018 CNRT
ASSIGNED TO EXAMINER
Jul 7, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 7, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 5, 2018 REPR